LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,349,085 | -23.6% | 451,825 | -21.5% | 0.00% | -25.0% |
| Q2 2023 | $39,708,957 | +48.1% | 575,242 | +3.5% | 0.00% | +33.3% |
| Q1 2023 | $26,811,000 | +113592.6% | 556,016 | +17.7% | 0.00% | 0.0% |
| Q4 2022 | $23,582 | -99.9% | 472,401 | -8.2% | 0.00% | 0.0% |
| Q3 2022 | $21,001,000 | -19.8% | 514,734 | +8.1% | 0.00% | -25.0% |
| Q2 2022 | $26,201,000 | +77.8% | 476,380 | +17.5% | 0.00% | +100.0% |
| Q1 2022 | $14,733,000 | +27.4% | 405,401 | +63.4% | 0.00% | +100.0% |
| Q4 2021 | $11,563,000 | +133.5% | 248,071 | +153.4% | 0.00% | 0.0% |
| Q3 2021 | $4,951,000 | +67.9% | 97,912 | +36.4% | 0.00% | – |
| Q2 2021 | $2,948,000 | +56.1% | 71,809 | +10.3% | 0.00% | – |
| Q1 2021 | $1,888,000 | +65.3% | 65,082 | +60.4% | 0.00% | – |
| Q4 2020 | $1,142,000 | -1.7% | 40,563 | +7.7% | 0.00% | – |
| Q3 2020 | $1,162,000 | +445.5% | 37,647 | +652.9% | 0.00% | – |
| Q2 2020 | $213,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |